400,0
+0,00%
2026-10-16
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.1% | -0.0% | 2 / 3 | -1.6% | -1.14 pp | -26.76 pp | -277.5% | -326.19 | — | 1,6 | −1,6% | −14,7 | −1,3% | — | -0.53 | — |
| Pts | 0 | 0 | 8 | 0 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 400,0 (close price on 2026-10-16)EPS (TTM): −1.134,4
Financial charts
1.Revenue & growth
VND bn1,58Q2/26
1.Revenue & growth
VND bn1,58Q2/26
2.Profit & growth
VND bn-14,7Q2/26
3.Profit mix (Penman)
VND bn-58,7Q2/26
4.Margins & cost structure
%38.3%Q2/26
5.Returns & cash cycle
% · days-30.5%Q2/26
Outlier warning: 11 period(s) outside -1.825…1.825 days, drawn at the limit
6.Earnings quality & cash
VND bn1,38Q2/26
7.Asset structure
VND bn193Q2/26
8.Funding & debt health
VND bn · times193Q2/26
9.Revenue backlog
VND bn4,77Q2/26
10.Valuation
times · %-0,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-284Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26